NCT00947167 2017-03-03A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine TumorsStanford UniversityPhase 2 Terminated4 enrolled 5 charts
NCT00204373 2012-10-30Treatment of Zollinger-Ellison Syndrome With PrevacidUniversity of Alabama at BirminghamPhase 4 Completed72 enrolled 8 charts